Overview

Europe Bioinformatics Market is poised to value over USD 6.43 billion by 2028 end at a CAGR of over 14.3% during the forecast period 2022 to 2028.

The rising requirement of bioinformatics in clinical diagnostics and manufacturing newer medicines, increasing need for protein and nuclei acid sequencing, growing need for integrated bioinformatics systems in the fields of genomics and proteomics and the increased governmental initiatives are some of the factors responsible for the growth of the Europe bioinformatics market. High costs, lack of skilled labor are some of the constraints of the market growth.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Europe Bioinformatics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Europe Bioinformatics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Europe Bioinformatics Market:

• AGILENT TECHNOLOGIES
• AFFYMETRIX INC.
• APPLIED BIOLOGICAL MATERIALS
• 3RD MILLENIUM INC.
• ILLUMINA INC.
• THERMO FISHER SCIENTIFIC INC.
• QIAGEN N.V
• BIOMAX INFORMATICS AG
• DNA NEXUS INC.
• VICTUS INC.
• WATERS CORP.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Europe Bioinformatics Market Segmentation:

By Sector

• Animal Biotechnology
• Environmental Biotechnology
• Agricultural Biotechnology
• Forensic Biotechnology
• Medical Biotechnology

By Products and Services

• Bioinformatics Platforms
• Knowledge Management Tools
• Bioinformatics Services

By Application

• Proteomics
• Transcriptomics
• Molecular Phylogenetics
• Chemo informatics
• Drug Design and Genomics

By Region

• Germany
• U.K
• France
• Italy
• Spain
• Russia
• Poland
• Switzerland
• Romania
• Rest of Western Europe.

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the Europe Bioinformatics Market By Sector, By Products and Services, By Application, and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— Germany, U.K, France, Italy, Spain, Russia, Poland, Switzerland, Romania, Rest of Western Europe.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
        1.1 Objectives of the Study 
        1.2 Market Definition 
        1.3 Market Scope 
               1.3.1 Years Considered for the Study
               1.3.2 Market Covered
        1.4 Currency 
        1.5 Limitations 
        1.6 Stakeholders 
 2.  Research Methodology 
        2.1 Research Data 
             2.1.1 Secondary Data
                 2.1.1.1 Key Data From Secondary Sources
             2.1.2 Primary Data
                 2.1.2.1 Key Data From Primary Sources
        2.2 Market Size Estimation 
        2.3 Market Breakdown and Data Triangulation 
        2.4 Assumptions for the Study  
3. Executive Summary
        3.1 Market Outlook
        3.2 Segment Outlook
        3.3 Competitive Insights
4. Europe Bioinformatics Market Variables, Trends & Scope
       4.1. Market Lineage Outlook
       4.2. Penetration and Growth Prospect Mapping
       4.3. Industry Value Chain Analysis
       4.4. Cost Analysis Breakdown
       4.5. Technology Overview
       4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards And Compliances
5. Market Overview
     5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus of Biotech Companies on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Europe Bioinformatics Market Analysis Tools
         6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
         6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
         6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
         6.4. Market Entry Strategies
         6.5. Case Studies
7. Europe Bioinformatics Market , By Sector Historical Analysis and Forecast 2022-2028 (USD Million)
           7.1. Animal Biotechnology
           7.2. Environmental Biotechnology
                7.2.1. Alternative Energy Sources
                7.2.2. Waste Clean-Up/ Bioremediation
                7.2.3. Climate Change Studies
           7.3. Agricultural Biotechnology
                 7.3.1. Crop Yield Improvement
                 7.3.2. Post Resistance   
                 7.3.3. Improvement of Plant Resistance
                 7.3.4. Biodiversity Informatics
                 7.3.5. Nutritional Quality Improvement
            7.4. Forensic Biotechnology
            7.5. Medical Biotechnology
                 7.5.1. Drug Development
                 7.5.2. Clinical Diagnostics
                 7.5.3. Molecular Medicine
                         7.5.3.1. Personalized Medicine
                         7.5.3.2. Preventive Medicine
                  7.5.4. Gene Therapy
8. Europe Bioinformatics Market, By Products and Services and Services Historical Analysis and Forecast 2022-2028 (USD Million)
           8.1. Bioinformatics Platforms
                8.1.1. Sequence Analysis Platforms
                8.1.2. Sequence Alignment Platforms
                8.1.3. Sequence Manipulation Platforms
                8.1.4. Structural and Functional Analysis Platforms
           8.2. Knowledge Management Tools
                8.2.1. Generalized Knowledge Management Tools
                8.2.2. Specialized Knowledge Management Tools
           8.3. Bioinformatics Services
                8.3.1. Data Analysis
                8.3.2. Sequencing Services
                8.3.3. Database and Management Services
9. Europe Bioinformatics Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)
           9.1. Proteomics
           9.2. Transcriptomics
           9.3. Molecular Phylogenetics
           9.4. Chemo informatics
           9.5. Drug Design and Genomics
10. Europe Bioinformatics Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
     10.1. Introduction
     10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
            10.2.1. Germany
            10.2.2. U.K
            10.2.3. France
            10.2.4. Italy
            10.2.5. Spain
            10.2.6. Russia
            10.2.7. Poland
            10.2.8. Switzerland
            10.2.9  Romania
            10.2.10.Rest of Western Europe
11. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
         11.1. AGILENT TECHNOLOGIES
                11.1.1. Company Overview
                11.1.2. Product Portfolio
                11.1.3. SWOT Analysis
                11.1.4. Financial Overview
                11.1.5. Strategic Overview
         11.2. AFFYMETRIX INC.
                11.2.1. Company Overview
                11.2.2. Product Portfolio
                11.2.3. SWOT Analysis
                11.2.4. Financial Overview
                11.2.5. Strategic Overview
         11.3. APPLIED BIOLOGICAL MATERIALS
                11.3.1. Company Overview
                11.3.2. Product Portfolio
                11.3.3. SWOT Analysis
                11.3.4. Financial Overview
                11.3.5. Strategic Overview
        11.4. 3RD MILLENIUM INC.   
                11.4.1. Company Overview
                11.4.2. Product Portfolio
                11.4.3. SWOT Analysis
                11.4.4. Financial Overview
                11.4.5. Strategic Overview
         11.5. ILLUMINA INC.
                11.5.1. Company Overview
                11.5.2. Product Portfolio
                11.5.3. SWOT Analysis
                11.5.4. Financial Overview
                11.5.5. Strategic Overview
         11.6. THERMO FISHER SCIENTIFIC INC.
                11.6.1. Company Overview
                11.6.2. Product Portfolio
                11.6.3.  SWOT Analysis
                11.6.4. Financial Overview
                11.6.5. Strategic Overview          
        11.7. QIAGEN N.V
                11.7.1. Company Overview
                11.7.2. Product Portfolio
                11.7.3. SWOT Analysis
                11.7.4. Financial Overview
                11.7.5. Strategic Overview
         11.8. BIOMAX INFORMATICS AG
                11.8.1. Company Overview
                11.8.2. Product Portfolio
                11.8.3. SWOT Analysis
                11.8.4. Financial Overview
                11.8.5. Strategic Overview
         11.9. DNA NEXUS INC.
                11.9.1. Company Overview
                11.9.2. Product Portfolio
                11.9.3. SWOT Analysis
                11.9.4. Financial Overview
                11.9.5. Strategic Overview
         11.10. WATERS CORP.
                11.10.1. Company Overview
                11.10.2. Product Portfolio
                11.10.3.  SWOT Analysis
                11.10.4. Financial Overview
                11.10.5. Strategic Overview

12. Pre and Post COVID-19 Impact
    12.1. Positive influence on the healthcare industry
    12.2. The financial disruption of the manufacturing sector
    12.3. Impact of COVID-19 on emerging companies
    12.4. Significant mandates in the regulations initiated by healthcare administrations
    12.5. The overall economic slowdown of the developing and developed nations

13. FutureWise SME key takeaway points for Client

Tables

Figures